Equities

Nanjing Vishee Medical Technology Co Ltd

688580:SHH

Nanjing Vishee Medical Technology Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)30.29
  • Today's Change-0.61 / -1.97%
  • Shares traded994.78k
  • 1 Year change-37.99%
  • Beta--
Data delayed at least 15 minutes, as of Nov 15 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year Nanjing Vishee Medical Technology Co Ltd grew revenues 43.72% from 321.62m to 462.22m while net income improved 45.22% from 93.83m to 136.26m.
Gross margin70.21%
Net profit margin26.70%
Operating margin28.72%
Return on assets6.41%
Return on equity7.04%
Return on investment6.92%
More ▼

Cash flow in CNYView more

In 2023, cash reserves at Nanjing Vishee Medical Technology Co Ltd fell by 93.87m. However, the company earned 134.20m from its operations for a Cash Flow Margin of 29.03%. In addition the company used 164.11m on investing activities and also paid 63.96m in financing cash flows.
Cash flow per share--
Price/Cash flow per share--
Book value per share16.83
Tangible book value per share14.81
More ▼

Balance sheet in CNYView more

Nanjing Vishee Medical Technology Co Ltd appears to have little financial risk as the company holds a substantial amount of cash on its books with little or no debt.
Current ratio8.60
Quick ratio8.31
Total debt/total equity0.0003
Total debt/total capital0.0003
More ▼

Growth rates in CNY

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 118.99% and 45.83%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
Div yield(5 year avg)--
Div growth rate (5 year)--
Payout ratio (TTM)90.64%
EPS growth(5 years)10.03
EPS (TTM) vs
TTM 1 year ago
-14.95
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.